HK97985A - Aminoalkyl furan derivative - Google Patents

Aminoalkyl furan derivative

Info

Publication number
HK97985A
HK97985A HK979/85A HK97985A HK97985A HK 97985 A HK97985 A HK 97985A HK 979/85 A HK979/85 A HK 979/85A HK 97985 A HK97985 A HK 97985A HK 97985 A HK97985 A HK 97985A
Authority
HK
Hong Kong
Prior art keywords
furan derivative
methyl
aminoalkyl
aminoalkyl furan
ethenediamine
Prior art date
Application number
HK979/85A
Other languages
English (en)
Inventor
Leslie Crookes Derek
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10516407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK97985(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HK97985A publication Critical patent/HK97985A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
HK979/85A 1980-10-01 1985-12-05 Aminoalkyl furan derivative HK97985A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031634 1980-10-01

Publications (1)

Publication Number Publication Date
HK97985A true HK97985A (en) 1985-12-13

Family

ID=10516407

Family Applications (1)

Application Number Title Priority Date Filing Date
HK979/85A HK97985A (en) 1980-10-01 1985-12-05 Aminoalkyl furan derivative

Country Status (29)

Country Link
US (2) US4521431A (fr)
JP (1) JPS5791983A (fr)
KR (1) KR870001431B1 (fr)
AT (1) AT389696B (fr)
AU (1) AU549119B2 (fr)
BE (1) BE890574A (fr)
CA (1) CA1202638A (fr)
CH (1) CH652122A5 (fr)
CZ (1) CZ280885B6 (fr)
DE (1) DE3139134A1 (fr)
DK (2) DK167794B1 (fr)
ES (1) ES8301954A1 (fr)
FR (1) FR2491067A1 (fr)
GR (1) GR72499B (fr)
HK (1) HK97985A (fr)
IE (1) IE51604B1 (fr)
IL (1) IL63968A (fr)
IT (1) IT1143237B (fr)
KE (1) KE3549A (fr)
LU (1) LU83661A1 (fr)
MY (1) MY8500747A (fr)
NL (1) NL8104482A (fr)
NZ (1) NZ198522A (fr)
PH (2) PH19489A (fr)
PT (1) PT73744B (fr)
SE (1) SE453500B (fr)
SK (1) SK277922B6 (fr)
ZA (1) ZA816809B (fr)
ZW (1) ZW24481A1 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR242029A1 (es) * 1983-07-15 1993-02-26 Richter Gedeon Vegyeszet Procedimiento para la preparacion del clorhidrato de 1-(2-(5- dimetilaminometil-2-(furilmetiltio)-etil))-amino-1-metilamino-2-nitroetileno
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride
CN1048984C (zh) * 1991-12-20 2000-02-02 多坎化学有限公司 晶形1呋喃硝胺氢氯化物的制备
WO1994020505A1 (fr) * 1993-03-12 1994-09-15 The Upjohn Company Acide libre cristallin de ceftiofur_______________________
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
US5670671A (en) * 1994-04-08 1997-09-23 Brantford Chemicals Inc. Process for the production of an improved form of form 1 ranitidine
CA2120874E (fr) * 1994-04-08 2002-01-08 Keshava Murthy Forme de la ranitidine de forme 1
DK0755393T3 (da) 1994-04-15 2001-12-17 Upjohn Co Nye krystalformer af 1-[5-methansulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazin
NZ272054A (en) * 1994-05-13 1996-05-28 Ranbaxy Lab Ltd Process for producing form 1 ranitidine hydrochloride
IN181699B (fr) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
IN181698B (fr) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CA2449419C (fr) * 1994-05-18 2011-09-06 Aventis Pharmaceuticals Inc. Methodes pour preparer des formes anhydres et hydratees de derives antihistaminiques de la piperidine; leurs formes polymorphes et pseudomorphes
DE69504156T2 (de) 1994-06-24 1998-12-24 Ranbaxy Laboratories, Ltd., New Delhi Verfahren zur Herstellung von Ranitidinhydrochlorid in der Kristallform 1
CA2201735A1 (fr) * 1994-11-18 1996-05-30 The Upjohn Company Nouvelle forme physiquement stable d'une fluoroquinolone
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5663381A (en) * 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
US5686588A (en) * 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
WO1997035853A1 (fr) * 1996-03-25 1997-10-02 Hoechst Marion Roussel, Inc. Procede de preparation de chlorhydrate de ranitidine de forme 1
DK0987256T3 (da) * 1997-08-08 2002-02-11 Aventis Pharma Gmbh Krystalform af N-(4-trifluormethylphenyl)-5-methylisoxazol-4-carboxylsyreamid
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
IT1317858B1 (it) * 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
AR040661A1 (es) * 2002-07-26 2005-04-13 Theravance Inc Diclorhidrato cristalino de n-{2-[-((r)-2-hidroxi-2-feniletilamino)fenil]etil}-(r)-2hidroxi-2-(3-formamido-4-hidroxifenil)etilamina, agonista del receptor adrenergico beta 2
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
RU2005117630A (ru) * 2002-11-08 2006-01-20 Дов Фармасьютикал, Инк. (Us) Полиморфы гидрохлорида бицифадина
TW200510277A (en) * 2003-05-27 2005-03-16 Theravance Inc Crystalline form of β2-adrenergic receptor agonist
US7384557B2 (en) * 2003-07-14 2008-06-10 Applied Ambient Extraction Process Consultants, Llc Method and apparatus for removing solute from a solid solute-bearing product
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
AU2006275870B2 (en) 2005-07-27 2013-01-10 Otsuka America Pharmaceutical, Inc. Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
JP2010506932A (ja) * 2006-10-20 2010-03-04 シノファーム シンガポール ピーティーイー，リミテッド 結晶性の無水ドセタキセルの製造方法
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
EP2167083B1 (fr) * 2007-06-06 2015-10-28 Euthymics Bioscience, Inc. 1- hétéroaryl-3-azabicyclo[3.1.0]hexanes, leurs méthodes de préparation et leur utilisation comme médicaments
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
TW201011043A (en) * 2008-06-20 2010-03-16 Chugai Pharmaceutical Co Ltd Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
CA2837453C (fr) * 2011-06-30 2017-04-11 Toray Industries, Inc. Cristaux de derive de glycine et utilisation pharmaceutique de ceux-ci
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
CN106397374A (zh) * 2015-05-26 2017-02-15 烟台市华文欣欣医药科技有限公司 一种制备治疗胃病的药物盐酸雷尼替丁化合物的方法
CN105030694A (zh) * 2015-08-04 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂
CN104971053A (zh) * 2015-08-05 2015-10-14 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化系统疾病的药物盐酸雷尼替丁组合物片剂
CN105055331A (zh) * 2015-08-31 2015-11-18 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化性溃疡的药物盐酸雷尼替丁组合物颗粒剂
WO2021079183A1 (fr) * 2019-10-21 2021-04-29 Sms Pharmaceuticals Limited Forme cristalline 2 du chlorhydrate de ranitidine exempte de solvant alcool isopropylique et exempte d'impureté de nitrosamine (ndma)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL63968A0 (en) 1981-12-31
CH652122A5 (fr) 1985-10-31
AU7595581A (en) 1982-04-08
DK436281A (da) 1982-04-02
DK33792D0 (da) 1992-03-12
DE3139134C2 (fr) 1990-04-19
SE8105812L (sv) 1982-04-02
ZA816809B (en) 1983-05-25
FR2491067B1 (fr) 1984-09-07
KR870001431B1 (ko) 1987-08-06
PT73744B (en) 1983-10-31
IE51604B1 (en) 1987-01-21
SK403591A3 (en) 1995-08-09
AU549119B2 (en) 1986-01-16
FR2491067A1 (fr) 1982-04-02
SK277922B6 (en) 1995-08-09
ES505951A0 (es) 1983-01-01
JPS5791983A (en) 1982-06-08
PH21761A (en) 1988-02-18
US4672133A (en) 1987-06-09
GR72499B (fr) 1983-11-15
US4521431A (en) 1985-06-04
AT389696B (de) 1990-01-10
SE453500B (sv) 1988-02-08
MY8500747A (en) 1985-12-31
JPH0443070B2 (fr) 1992-07-15
DK167794B1 (da) 1993-12-13
NL8104482A (nl) 1982-05-03
DK33792A (da) 1992-03-12
IL63968A (en) 1985-10-31
PH19489A (en) 1986-05-14
NZ198522A (en) 1985-07-12
DK167923B1 (da) 1994-01-03
KE3549A (en) 1985-08-16
ATA422281A (de) 1989-06-15
PT73744A (en) 1981-10-01
CZ403591A3 (en) 1994-01-19
KR830007070A (ko) 1983-10-14
CA1202638A (fr) 1986-04-01
BE890574A (fr) 1982-04-01
ES8301954A1 (es) 1983-01-01
ZW24481A1 (en) 1983-04-27
IE812287L (en) 1982-04-01
IT1143237B (it) 1986-10-22
CZ280885B6 (cs) 1996-04-17
DE3139134A1 (de) 1982-05-19
LU83661A1 (fr) 1983-06-08
IT8149407A0 (it) 1981-10-01

Similar Documents

Publication Publication Date Title
ES8301954A1 (es) Mejoras introducidas en un procedimiento para la obtencion del hidrocloruro de ranitidina
AU545320B2 (en) Benzothiophene and benzo furan sulfonamides
NO160921C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktiv syn-isomer av en 3-vinyl-3-cefem-forbindelse.
IL53520A (en) Derivatives of 5-(3,4-dihydroxy phenyl)2-oxazolidinones (and 2-thiazolidinones)and thiones and a process for their production
JPS5412372A (en) Thiazolidine derivative and its preparation
AU541305B1 (en) Derivatives of 5-(2-imidazoline-2-yl)-amino pyrimidines
ES456610A1 (es) Procedimiento para preparar derivados de sulfonamida.
JPS5484564A (en) Novel gamma-butyrolactone derivative and its preparation
EP0373002A3 (fr) L'utilisation des acides thiazolidine-4-carboniques, substitués en position 2, pour le traitement de la cataracte
AU583311B2 (en) N-(6-Methoxy-5-(perfluoroalkyl)-1-naptholyl)-N- methylglycines and their thionaphthoyl analogs
MY130559A (en) Process for the manufacture of form 1 ranitidine hydrochloride
NO802593L (no) Fremgangsmaate ved fremstilling av 5-(klorfenyl)-6h-1,3,4-thiadiazin-2-aminer
IE44358L (en) Isothioureas
IL70401A (en) N(2-((5-(tricycloalkylamino-methyl)-2-furanyl)-methyl-thio)-ethyl) n'-2-nitro-1,1-ethenediamine derivatives,their preparation and pharmaceutical compositions containing them
GB2015524A (en) Pyridine derivatives
FR2455687B1 (fr) Pompe rotative, notamment destinee a former coeur artificiel
NO164771C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.
JPS53108936A (en) Epolysuccinic monoester derivative
IT8026361A0 (it) Procedimento di preparazione della n-[2-[[[5-(dimetilamino)-metil-2-fu ranil]-metil]-ito]-etil]-n'-metil-2-nitro-1,1-etilendiamina
JPS5283773A (en) Novel indene derivative
NO895159D0 (no) Fremgangsmaate for fremstilling av antiretrovirale aryloxysubstituerte furanketoner.
JPS54109960A (en) 1,3-beta-d-glucan derivative, its use and preparation
JPS5350196A (en) Novel 4hhpyrido *2*33d**1*3* oxazinee44one derivatives
AU491239B2 (en) Thia furans and furan thiols, processes for making same and their use as flavoring agents
JPS5334779A (en) Novel piperazine derivatives and thier preparation

Legal Events

Date Code Title Description
PE Patent expired